Henry Schein Intrinsic Value Calculator – HENRY SCHEIN Reports 3.1% Increase in Total Revenue for Q3 FY2023 with USD 3162.0 Million

☀️Earnings Overview

On November 13, 2023, HENRY SCHEIN ($NASDAQ:HSIC) reported its earnings results for Q3 FY2023, with total revenue reaching USD 3162.0 million, a 3.1% growth compared to the same period of the prior year. Unfortunately, net income decreased 8.7% year-over-year to USD 137.0 million as of September 30, 2023.

Analysis – Henry Schein Intrinsic Value Calculator

GoodWhale conducted an in-depth analysis of HENRY SCHEIN‘s fundamentals to determine its fair value. We used our proprietary Valuation Line to calculate the fair value of HENRY SCHEIN’s share, and it came out to be around $82.1. Currently, the HENRY SCHEIN stock is traded at $67.5, which is comparatively lower and is undervalued by 17.8%. Thus, investors might find this company to be an attractive investment opportunity right now. More…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Henry Schein. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Henry Schein. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Henry Schein. More…

Key Ratios Snapshot

Some of the financial key ratios for Henry Schein are shown below. More…

Peers

Henry Schein Inc is one of the largest companies in the dental supplies industry.

However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.

– Healthlead PCL ($SET:HL)

LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.

– Patterson Companies Inc ($NASDAQ:PDCO)

Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.

– Alfresa Holdings Corp ($TSE:2784)

Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.

Summary

Henry Schein reported total revenue of $3162.0 million for the third quarter of FY2023, representing a 3.1% year-over-year increase. Despite the increase in revenue, the company’s net income was down 8.7% year-over-year, to $137.0 million as of September 30, 2023. Despite this decline, stock prices moved up on the day of the announcement. For investors, Henry Schein’s third quarter results present a mixed picture: while revenue had increased, net income had declined.

However, the stock price increase is a sign of market confidence in Henry Schein’s performance. Investors looking to capitalize on the momentum should consider investing in the company’s stock.